AlphaYouMH
Insider selling
Mark Hopman sold $681K of Beta Bionics, Inc. (BBNX) stock
Mark Hopman, Chief Commercial Officer of Beta Bionics, Inc. (BBNX), sold 36,870 shares of BBNX stock worth $681K, per an SEC Form 4 filed Sep 10, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Sep 9, 2026, 1 day before it was made public.
BBNX has moved +30.9% since the trade date, from $17.42 to $22.81 (Sep 22, 2026 close).
- Traded
- Sep 9, 2026
- Disclosed
- Sep 10, 2026
- Filing delay
- 1 day
- Price since
- +30.9%
- Role
- Chief Commercial Officer
- Source
- SEC Form 4
More BBNX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.